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Abstract
Kinesins are a family of motor proteins conserved throughout eukaryotes. In our present study we characterize a novel
kinesin, Kinesin
CaaX, orthologs of which are only found in the kinetoplastids and not other eukaryotes. Kinesin
CaaX has the
CVIM amino acids at the C-terminus, and CVIM was previously shown to be an ideal signal for protein farnesylation in
T. brucei. In this study we show Kinesin
CaaX is farnesylated using radiolabeling studies and that farnesylation is dependent
on the CVIM motif. Using RNA interference, we show KinesinCaaX is essential for T. brucei proliferation. Additionally RNAi
Kinesin
CaaX depleted T. brucei are 4 fold more sensitive to the protein farneysltransferase (PFT) inhibitor LN-59, suggesting
that Kinesin
CaaX is a target of PFT inhibitors’ action to block proliferation of T. brucei. Using tetracycline-induced exogenous
tagged Kinesin
CaaX and Kinesin
CVIMdeletion (non-farnesylated Kinesin) expression lines in T. brucei, we demonstrate Kinesin
CaaX
is farnesylated in T. brucei cells and this farnesylation has functional effects. In cells expressing a CaaX-deleted version of
Kinesin, the localization is more diffuse which suggests correct localization depends on farnesylation. Through our
investigation of cell cycle, nucleus and kinetoplast quantitation and immunofluorescence assays an important role is
suggested for KinesinCaaX in the separation of nuclei and kinetoplasts during and after they have been replicated. Taken
together, our work suggests Kinesin
CaaX is a target of PFT inhibition of T. brucei cell proliferation and Kinesin
CaaX functions
through both the motor and farnesyl groups.
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Introduction
Trypanosoma brucei species are the causative agents of Human
African Trypanosomiasis (HAT) or African sleeping sickness in
humans and the wasting disease, nagana, in cattle. There were
9878 new HAT cases reported to the WHO in 2009 [1], notably
the first decline below 10,000 reported cases since 1960 due in part
to increased national sleeping sickness control programs [1] and
disease mapping [2]. However, as resources are limited in many
parts of rural Africa and surveillance in many areas is not yet
routine, many cases go unreported. The WHO estimates from
30,000 to 70,000 new cases of HAT occur per year [3].
Trypanosoma species can also infect livestock including goats, sheep,
pigs, donkeys and cattle [4]. This has an impact economically as
many parts of Africa are unable to raise livestock for consumption
and sale due to this parasite [4].
Currently no vaccines are effective at preventing Trypanosoma
brucei infections. Existing medical therapies do exist, however
many are toxic, require long treatment regimens and are difficult
to administer [3]. Drug resistance is also a concern [5–8] and new
drugs are urgently needed.
In our search for possible drug targets against protozoan
parasites we have characterized the enzymes responsible for
protein prenylation [9–19]. Prenylation is the posttranslational
modification of proteins by the covalent addition of the isoprenyl
lipid farnesyl or geranylgeranyl [20,21]. In farnesylation, the
fifteen carbon farnesyl group from farnesyl pyrophosphate is
added to the C of the CaaX motif, a cysteine-containing four
amino acid residue motif at the C-terminus of some proteins. The
aa represent two aliphatic residues and the X represents amino
acids including serine, methionine, alanine, threonine or gluta-
mine [20]. Geranylgeranylation refers to the addition of a twenty-
carbon geranylgeranyl group to the CaaX motif where X is
commonly a leucine or phenylalanine. Prenylation modifications
create a hydrophobic C-terminus that allows the protein to
interact with the cell membrane, membrane-bound organelles,
other cellular proteins and hydrophobic surfaces. Addition of the
farnesyl or geranylgeranyl groups is mediated in mammalian cells
by three heterodimeric enzymes: protein farneysltransferase (PFT),
protein geranylgeranyltransferase type I (PGGT-I) and protein
geranylgeranyltransferase type II (PGGT-II) [20,21].
Previously our work has investigated T. brucei PFT (TB-PFT)
enzyme as a potential drug target for developing new drugs against
T. brucei [9–16]. TB-PFT covalently-links a farnesyl group from
farnesyl-pyrophosphate to the cysteine on the CaaX motif. In
mammals, both PFT and PGGT-I share the a-subunit, but
bioinformatic studies suggest that T. brucei lacks a gene encoding
the b-subunit of PGGT-I and biochemical studies suggest T. brucei
lacks PGGT-I activity [14]. Our group has shown that PFT
inhibitors inhibit prenylation of T. brucei proteins and inhibit T.
brucei growth [10–11]. We have also demonstrated that T. brucei
parasites are more sensitive to PFT inhibitors than T. cruzi
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the b-subunit homolog of PGGT-I, Gene DB# Tc00.
1047053508817.150 [18]. PGGT-I has been shown to act on
many of the same substrates that PFT normally prenylates [20]
and T. cruzi PGGT-I may provide a redundant function for PFT
and thus explain why T. cruzi is less sensitive to PFT inhibitors
than T. brucei. Taken together, these data suggest TB-PFT is a
valid target for drug development for HAT therapy.
Conventionally the X amino acids in CaaX motifs modified by
mammalian PFT include serine, methionine, alanine and
glutamine. In contrast, our work has shown that while TB-PFT
readily farnesylates CaaX targets containing a methionine or
glutamine in the X position, it does not readily modify CaaX
targets with serine, threonine, alanine or cysteine in the X position
[12]. We have also identified inhibitors that are ten-fold more
potent against TB-PFT than mammalian PFT [11]. This restricted
preference to TB-PFT and not the mammalian PFT is desirable
for drug design targeted to kill T. brucei in humans but not affect
the human form of the enzyme. However, of the PFT inhibitors
that had sufficient potency against TB-PFT, none had desirable in
vivo pharmacokinetics [15]. Therefore we began the study of the
preferred CaaX containing proteins that have the methionine in
the X position to investigate proteins downstream of TB-PFT in
order to identify new drug targets.
We have shown the CVIM motif is a favored target of TB-PFT
[12]. Only two of all known C-terminal CaaX -containing proteins
have the CVIM CaaX -motif in T. brucei brucei (Fig. S1). One
CVIM-containing gene, Gene DB# Tb10.70.0590, is a predicted
ras-like small GTPase and has been previously characterized in T.
cruzi [19]. The second, Gene DB# Tb927.10.12440, was
annotated as a kinesin-like protein with a predicted molecular
weight of 91 kilodaltons. As we had observed a decrease in
prenylation of proteins at approximately this molecular weight in
protein farnesyl transferase inhibitor (PFTi) -treated T. brucei [11]
and because no other proteins with a CaaX motif besides
Tb927.10.12440 were between 77 and 98 kilodaltons (Fig. S1),
we set out to further investigate this protein. Bioinformatics studies
reveal this protein contains motifs common to the kinesin family of
motor proteins. Due to the presence of the CaaX motif we have
named the protein Kinesin
CaaX. In our present study we
demonstrate this protein is farnesylated in T. brucei cells and this
farnesylation has functional effects. With Kinesin
CaaX protein
depletion using RNAi we demonstrate the importance of
Kinesin
CaaX for T. brucei proliferation. We characterize tetracy-
cline-induced exogenous tagged Kinesin
CaaX expression in T.
brucei and localize it in the cell and show this localization to be
dependent on prenylation. Through our investigation of cell cycle,
nucleus and kinetoplast quantitation and immunofluorescence
assays we hypothesize an important role for Kinesin
CaaX in
nuclear and kinetoplast segregation.
Results
Kinesin
CaaX has motifs consistent with kinesin motor
proteins
All motifs common to the kinesin family of motor proteins are
present in Kinesin
CaaX. Kinesins are proteins that convert the
chemical energy from ATP into a mechanical force to move along
microtubules [22]. Kinesins include a diverse range of molecules
organized into nearly 20 families based on the location of the
motor domain in the protein and regions of homology outside of
the motor domain [23]. Kinesins from various families have
diverse functions and may function as monomers, dimers or
tetramers [23]. Kinesins are implicated in moving a wide range of
cellular macromolecules, termed ‘‘cargo’’, including vesicles,
organelles and chromosomes [23]. Kinesin
CaaX cannot be placed
in any known kinesin family due to low homology with previously
characterized kinesin families outside the motor domain [24].
Kinesin
CaaX is similar in domain layout to the canonical kinesin
family 1 members that function as homodimers with two large
globular motor domains followed by a coiled-coil neck [25]. The
globular motor domain interacts with microtubules and the coiled-
coil neck is associated with dimerization. Movement along
microtubules has been described as stepwise using 8-nm steps in
an asymmetric hand-over-hand mechanism [22]. Structural
features involved in force generation in the kinesin superfamily
are conserved in Kinesin
CaaX when compared to known kinesins
in sea urchins, mice and humans (Fig. 1A) as shown by MUSCLE
alignment [26]. The R2 domain, P Loop, Switch I and the relay
helix Switch II [27] domains are conserved in Kinesin
CaaX.
Kinesin
CaaX from T. brucei brucei has 832 residues with the motor
domain located at the amino terminus of the molecule, followed by
a coil region that is predicted to form a coiled coil upon
dimerization and the CaaX motif at the carboxy terminus (Fig. 1B).
Based on the presence of a coil domain and the motor domain at
the amino-terminus of the protein, we predict Kinesin
CaaX moves
towards the plus-end of microtubules as a dimer.
Kinesin
CaaX is conserved in other pathogenic
kinetoplastids but not other eukaryotes
Homology studies utilizing OrthoMCL [28] do not detect
orthologs to T. brucei brucei Kinesin
CaaX in higher eukaryotes, but
do predict a single orthologous copy in other pathogenic
kinetoplastids including Leishmania braziliensis, Leishmania infantum,
Leishmania major, Leishmania mexicana mexicana, Trypanosoma brucei
gambiense, Trypanosoma brucei rhodesiense, Trypanosoma congolense,
Trypanosoma cruzi and Trypanosoma vivax (Fig. 1C, S2 & S3). The
orthologous members vary moderately in molecular weight, yet in
each case retain the CaaX motif at the carboxy terminus (Fig. 1C).
The evolutionary relationship of Kinesin
CaaX was analyzed using
CLUSTALW Biology Work Bench, Version 3.2 [29]. This
analysis demonstrates T. brucei gambiense Kinesin
CaaX is most
closely related to that of T. brucei brucei followed by the other
Trypanosoma species and then the Leishmania species (Fig. S3). As
Kinesin
CaaX is conserved throughout kinetoplastids but not other
higher eukaryotes, we hypothesize this kinesin performs a
conserved role in kinetoplastid cell biology.
Kinesin
CaaX has an ATP-dependent motor capable of
movement with microtubules
Some predicted kinesins in eukaryotic organisms attach to
microtubules but do not demonstrate motor activity. Truncated
kinesin genes expressing presumably non-motile kinesins have
been suggested to be genetic remnants of once functional proteins
[30]. Non-motile kinesins may also facilitate other not yet defined
microtubule-protein interactions. To test for motor activity in
Kinesin
CaaX, we used an in vitro microtubule motility assay using
rhodamine-labeled microtubules and time lapse fluorescence
microscopy. Truncated recombinant Kinesin
CaaX containing the
motor domain and the coil dimerization domain (Fig. S4A) led to
the processive movement of fluorescent microtubules, in a linear
direction, in the presence of ATP (Fig. S4B). Control extracts
expressing b-galactosidase, non-motor recombinant protein plus
ATP did not lead to the movement of fluorescent microtubules
(Fig. S4C). Kinesin
CaaX without ATP also did not lead to the
movement of fluorescent microtubules (data not shown). Thus,
both ATP and the Kinesin
CaaX motor domain were required to
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CaaX
has motor activity with microtubules in an ATP dependent
manner. We hypothesize Kinesin
CaaX uses this ATP-dependent
motor activity to move cargo along the microtubule network
within T. brucei cells. As a more sophisticated biophysical study
would require a full length protein isolated from T. brucei,w e
proceeded to studies to elucidate the functional significance of
Kinesin
CaaX in the parasite.
Reduction of Kinesin
CaaX expression in the bloodstream
form inhibits growth and contributes to mitotic delay
T. brucei and other kinetoplastids have a complex life cycle with
various developmental forms. Two forms of T. brucei brucei can be
cultured and studied in the lab; the mammalian bloodstream
(trypomastigote) form and the insect (procyclic) form. We utilized
RNA interference (RNAi) in order to test the effect of reduced
Kinesin
CaaX expression on the phenotype of bloodstream
trypomastigotes, as trypomastigotes are the forms most relevant
to human and animal disease. We cloned a unique portion of the
Kinesin
CaaX ORF into a tetracycline-inducible construct designed
with opposing T7 promoters that induce dsRNA and made stably
transfected T. brucei brucei bloodstream parasites. Within 72 hours
of tetracycline induction of Kinesin
CaaX RNAi, a dramatic growth
defect occurred in two independently derived clones (Fig. 2A). RT-
PCR for Kinesin
CaaX mRNA reveals levels from induced with
tetracycline were reduced to 18% (Clone A) and 32% (Clone B) of
uninduced controls by 48 hours. Levels of Kinesin
CaaX mRNA of
no-tetracycline controls were similar to quantities observed in non-
transfected controls. Further work was carried out with clone A
because of its superior RNA reduction after tetracycline induction.
Protein levels of Kinesin
CaaX clone A were depleted to
undetectable levels as shown by Western blot analysis (Fig. 2B).
Growth arrest and correlating mRNA and protein depletion of
Kinesin
CaaX support the hypothesis that Kinesin
CaaX is essential
for growth in the bloodstream form.
T. brucei cells cannot be easily synchronized to study the cell
cycle, but kinetoplast and nuclear DNA quantitative analysis by
fluorescence microscopy of DAPI stained fixed cells can be used to
detect alterations in cell cycle progression. G1 cells are diploid and
have 1 kinetoplast and 1 nucleus (1K1N). Kinetoplast replication
and division occurs before nuclear DNA replication is completed,
such that cells undergoing nuclear DNA synthesis (S phase) can
have an elongated kinetoplast (still 1K1N) or 2 kinetoplasts and 1
nucleus (2K1N) [30]. Cells with 2 kinetoplasts and 2 nuclei (2K2N)
have completed mitotic division and are in G2 or mitosis (G2/M)
phase. Cells with greater than 2K2N have not completed
Figure 1. Kinesin
CaaX has motifs consistent with plus-end directed kinesin proteins and is conserved in pathogenic kinetoplastids.
(A) Key kinesin domains are conserved in Tb10.389.1270 when sequences are compared to kinesins in sea urchins, mice and humans. The
corresponding GenBank accession numbers for each corresponding protein are Homo sapiens NP_612565.1, Mus musculus NP_03246, and
Strongylocentrotus purpuratus P46871. (B) Structural features and domain architecture of Kinesin
CaaX. Kinesin
CaaX has 832 residues. Represented are
the R2 domain (teal), the phosphate binding loop or P Loop (purple), Switch I (blue) and Switch II (magenta) regions, the coil region (fish scales) that
facilitates dimerization, and CaaX motif (yellow) that is predicted to act as a farnesylation signal. (C) Comparison of Kinesin
CaaX orthologs in other
kinetoplastids shows CaaX motif and size conservation in other pathogenic kinetoplastid species.
doi:10.1371/journal.pone.0026508.g001
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CaaX in the bloodstream form inhibits growth and contributes to mitotic delay. (A) Growth of tetracycline-
inducible RNAi Kinesin
CaaX knockdown cells with and without tetracycline induction. RNAi cell lines were constructed with the tetracycline-inducible
vector to induce double stranded RNA specific to Kinesin
CaaX. Kinesin
CaaX A and B represent two different clones. Untransfected and uninduced (2tet)
cells are used as controls. Broken lines indicate tetracycline added to cultures during growth (+). Kinesin
CaaX RNAi-induction results in a significant
growth defect in both A & B clones. (B) Western blot analysis of Clone A whole cell lysates of bloodstream (BSF) probed with rabbit serum from
animals immunized with a fragment of recombinant Kinesin
CaaX. Non-induced (2) and tetracycline induced (+) cells reveal Kinesin
CaaX protein levels
(91 kDa) were diminished by 48 hours of tetracycline-induction. A 21 kDa non-specific band from the Western Blot serves as a loading control. The
same loading ratio of 2 to + tetracycline protein was confirmed in non-transferred Coomassie stained PAGE lanes (data not shown). (C) Fluorescence
microscopy of DAPI stained cells demonstrates a shift in kinetoplast and nuclei content of Kinesin
CaaX-depleted cells. Shown are the mean and SD of 2
experiments at 24 hours after tetracycline induction performed with clone A cells. Control cells are nontransfected controls treated with tetracycline.
Similar results were seen with control transfected cells that were not induced with tetracycline (data not shown). Compared with control cells,
Kinesin
CaaX-depleted T. brucei cells have a larger proportion of cells with 2 kinetoplasts and 2 nuclei (2K2N) and an increased number of cells with
greater than two nuclei (other). Statistical differences were assessed with a Student T Test. (D) Flow cytometry reveals Kinesin
CaaX depleted T. brucei
cells, compared with non-induced cells, is dominated by the appearance of an increased number of cells with lower than G1 DNA content, particularly
evident at 48 hours after induction. The Y axis represents the number of cells and the X axis is DAPI fluorescence, representing DNA content. The lines
represent histograms of cells. Peaks representing G1 and G2/M are indicated. (E) Photomicrographs of phase and DAPI-stained T. brucei blood-stage
cells. Depletion of Kinesin
CaaX (RNAi) leads to cell morphology changes with cells demonstrating a rounded cell body and detached flagella compared
to the non-induced cells (Control). The RNAi examples represent two typical cells, with altered morphology, observed at 48 hrs after tetracycline
induction.
doi:10.1371/journal.pone.0026508.g002
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sin
CaaX RNAi for 24 hours, compared to uninduced cells,
demonstrate a decrease of 1K1N cells from 81% to 57%
(p=0.013 Student T test), an increase in 2K2N cells from 9.5%
to 20% (p=0.026 Student T test) and an increase in of cells with
greater than 2K2N (other) 1.5% to 17% (p=0.002 Student T
test)(Fig. 2C). No 1K0N cells were observed. Flow cytometry
reveals RNAi depletion of Kinesin
CaaX results in a slight
proportional increase in G2/M cells and a decrease in G1 cells,
at 24 hours (Fig. 2D). However, the bulk of the events at 48 hours
have low DAPI fluorescence (Fig. 2D, right panel), suggesting that
there is an abundance of cell fragments with reduced DNA, likely
representing degenerating and dying cells. 1K1N cells undergoing
RNAi at 48 hours have a rounded cell body with detached flagella
and the DAPI staining appears weaker than non-induced cells
(Fig. 2E). Taken together, these data suggest Kinesin
CaaX is
essential for growth in the bloodstream form.
Kinesin
CaaX is farnesylated in T. brucei
Farnesyl pyrophosphate is used by T. brucei protein farnesyl
transferase to add farnesyl groups to CaaX-motifs and is generated
in a series of enzymatic steps from mevalonate [20]. In the
presence of simvastatin, mevalonate synthesis is inhibited, and T.
brucei cells incorporate scavenged mevalonalactone. Scavenged
mevalonalactone is incorporated into farnesyl-pyrophosphate and
used to farnesylate proteins [11]. We engineered a tetracycline-
inducible plasmid to ectopically express an amino-terminal
hemagglutinin-epitope-tagged full length copy of Kinesin
CaaX
(HA-Kinesin
CaaX). We made a second construct using site directed
mutagenesis, we deleted the twelve nucleotides corresponding to the
CVIM (CaaX) from the tetracycline-inducible HA-Kinesin
CaaX
construct and transfected the plasmid to make a tetracycline
inducible HA-Kinesin
CVIM deletion expressing T. brucei line. Tet-
inducible HA-Kinesin
CaaX, HA-Kinesin
CVIM deletion and control
(untransfected) T. brucei lines were grown in the presence of
3H-
mevalonalactone, simvastatin and tetracycline. Immunoprecipitation
with anti-HA antibodies shows tetracycline-induced HA-Kinesin
CaaX
immunoprecipitates had a statistically significant increase in
radioactive counts per minute (cpm)than control immunoprecipitates
(Fig. 3) (p=0.015, Student T test) and HA-Kinesin
CVIM deletion
(p=0.006, Student T test) while Kinesin
CVIM deletion did not have a
statistically significant difference to the control (p=0.10, Student T
test). These data support our previous finding that TB-PFT adds
farnesyl to CVIM peptides and is highly suggestive that CVIM of
HA-Kinesin
CaaX isfarnesylatedbyTB-PFTinT.brucei. This supports
the hypothesis that native Kinesin
CaaX is farnesylated by TB-PFT in
T. brucei cells.
Kinesin
CaaX localizes near dividing kinetoplasts and nuclei
To shed light on the localization of Kinesin
CaaX, we made an
antibody specific to a unique sequence in Kinesin
CaaX in T. brucei
cells and performed immunofluorescence. Despite trying multiple
fluorescent signal amplification protocols, expression of native
levels of Kinesin
CaaX appeared to be too weak to reliably and
reproducibly detect by immunofluorescence. We used the HA-
Kinesin
CaaX exogenous expression lines to study growth and
morphology. qPCR shows a 4.3 fold (SD=0.56) induction of
mRNA (Fig. 4A). Western blot using an anti-HA antibody reveals
induction of HA-Kinesin
CaaX following tetracycline (tet) addition
(Fig. 4A). Fluorescence microscopy of DAPI stained cells reveals
that induction of HA-Kinesin
CaaX results in an increase of cells
with the 2K1N configuration from 8% to 44% (p=0.0019,
Student T test) compared to non-induced cells, with a relative
decrease in 1K1N cells from 81% to 45.5% by 48 hours (Fig. 4B &
4C) (p=0.006, Student T test) (Fig. 4C). Flow cytometry analysis
on this tetracycline-inducible HA-Kinesin
CaaX-line reveals a slight
decrease in the G1 peak and a slight increase of events between the
G1 and G2/M peaks by 48 hours after tetracycline induction
(Fig. 4D) consistent with the increase in 2K1N cells. Induced cells
have a similar growth rate to control cells and uninduced cells (Fig.
S5). Additionally, very few cells with low amounts of DNA
(presumably dead cells, Fig. 4D) were seen after Kinesin
CaaX
induction compared with RNAi induction (Fig. 2D).
As we could not consistently detect native Kinesin
CaaX using
immunofluorescence, we used the HA-tagged-expression line for
localization studies. Exogenously expressed HA-Kinesin
CaaX local-
izes between the nucleus and kinetoplast in a small percentage of
1K1N containing cells but is not present in all 1K1N cells (Fig. 4E &
F). In general, 1K1N cells that have detectable HA-Kinesin
CaaX
have elongated and V-shaped kinetoplasts (Fig. 4F 1Kdiv1N),
indicative of initiation of kinetoplast replication [31]. Cells with
2K1N and 2K2N DNA content have more easily detectable HA-
Kinesin
CaaX relative to 1K1N cells (Fig. 4E & 4F). In 2K1N
containing cells, HA-Kinesin
CaaX localizes around the nucleus and
is enriched near theanteriorkinetoplast(Fig. 4E)and inpost-mitotic
2K2N cells, Kinesin
CaaX is found near the anterior kinetoplast,
between the nuclei, and surrounding the nuclei (Fig. 4E). Using the
anti-b-tubulin antibody KMX [32] we monitored KMX epitope
localization before and after HA-Kinesin
CaaX induction (Fig. 4F).
KMX localizes to b-tubulin in the microtubule corset of T. brucei
cells (Fig. 4F). Though the KMX b-tubulin localization looked
similar in uninduced cells and induced cells, HA-Kinesin
CaaX
appeared enriched in the b-tubulin between the nuclei of 2K2N
cells(Fig.4F). Theselocalizationdata support a roleforKinesin
CaaX
in separating nuclei and kinetoplasts.
Kinesin
CaaX localization is disrupted with CaaX deletion
Upon tetracycline induction Kinesin
CVIM deletion mRNA is
induced 13.9 fold (SD=6.5) as shown by RT-PCR and protein is
Figure 3. Kinesin
CaaX is farnesylated in T. brucei. Radioactivity
(CPM: counts per minute) found in HA-antibody immunoprecipitates from
induced HA-Kinesin
CaaX (Kinesin+tet), induced HA-Kinesin
CVIM deletion
(CVIM- +tet), and control non-transfected cells (Control+tet) extracts from
bloodstream form cells. Cells were treated with tetracycline, simvastatin
and incubated with
3H mevalonolactone for 48 hours. Radioactivity above
background is found only in the induced HA-Kinesin
CaaX –immunoprecip-
itates. Whole cell lysates pre-IP were compared using a scintillaton counter
to ensure equal lysate concentrations per reaction. Statistical differences
were assessed with a Student T Test.
doi:10.1371/journal.pone.0026508.g003
An Essential Farnesylated Kinesin in T. brucei
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e26508Figure 4. Kinesin
CaaX localizes near the nucleus and kinetoplast and is enriched in post-mitotic cells. (A) Left Western blot of whole cell
lysates of bloodstream form (BSF) T. brucei tagged HA- Kinesin
CaaX cell line either induced (+) or non-induced (2) for 48 hours. While more material is
loaded in the (2) non-induced lane, much more HA-Kinesin is observed in the (+) induced lane. Right Quantitative PCR (qPCR) showed induced cells
had 4.2 times more mRNA for Kinesin
CaaX than non-induced controls (error bars are SD). (B) DAPI staining and fluorescence microscopy reveals a
larger proportion of cells with 2 kinetoplasts and one nucleus (2K1N) and a reduction in 1K1N cells in tetracycline-induced Kinesin
CaaX T. brucei cells
compared with non-induced cells, with the effect becoming prominent at 48 hours (C) The mean and SD of 2 experiments at 48 hours. Statistical
analysis was performed using a Student T test. (D) Ectopic expression of Kinesin
CaaX results in a slight decrease in G1 cells and a slight increase in cells
between the G1 and G2/M peaks at 48 hours after tetracycline induction. (E) Cells were stained with DAPI to stain nuclear and kinetoplast DNA (blue),
anti-HA rat mAb primary and polyclonal anti-Rat IgG Cy5.5 (red) secondary 24 hours post-tetracycline induction. Cells with 2K1N and 2K2N DNA
content have an increased amount of Kinesin
CaaX relative to 1K1N cells. (F) Cells were stained with DAPI to stain nuclear and kinetoplast DNA (blue),
FITC-anti-mouse IgG to localize the KMX mouse monoclonal antibody (mAb) that binds b- tubulin (green) and anti-HA rat mAb primary and
polyclonal anti-rat IgG Cy5.5 (red) secondary that localize HA-Kinesin
CaaX 24 hours post tetracycline induction. b-tubulin localization demonstrates
these cells have normal morphology. The cell marked 1Kdiv1N has an elongated kinetoplast consistent with a kinetoplast that is undergoing division.
doi:10.1371/journal.pone.0026508.g004
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CVIM deletion
expressing-cells demonstrate a similar growth rate as control cells
for the first 72 hours and then demonstrate a slowed growth rate
by 96 hours post-induction (Fig. S5). Upon tetracycline induc-
tion, HA-Kinesin
CVIM deletion cells have a very similar nuclear
and kinetoplast quantitative profile to control unstimulated cells
at 24 and 48 hours (data not shown) consistent with flow
cytometry profiles of G1 and G2/M (Fig. 5B). While profiles of
the 24 and 48 hour time points after induction are very similar to
the non-induced control by 72 hours and at 96 hours after
induction, a large population of cells containing less than a G1
complement of DNA becomes apparent, suggestive of dying and
degenerating cells. This is consistent with the observed decrease
in growth by 96 hours (Fig. S5). Immunofluorescence microscopy
shows the HA-Kinesin
CVIM deletion has a more diffuse localization
in 1K1N, 2K1N and 2K2N cells than the HA-tagged
Kinesin
CaaX cells at 24 hours post-induction (Fig. 5C). Addition-
ally we observed cells with a rounded cell body some of which
disrupted the KMX antibody b-tubulin binding (Fig. 5C). This
cell morphology is similar to what is observed in cells undergoing
Kinesin
CaaX RNAi (Fig. 2E). Thus the exogenous expression of
Kinesin
CVIMdeletion led to a death phenotype similar to that seen
in RNAi depleted cells, but at later time points than that seen
with RNAi. Furthermore, Kinesin
CVIM deletion was found much
more diffusely localized throughout the cells than Kinesin
CaaX,
suggesting the farnesyl group contributes to proper localization.
Depletion of Kinesin
CaaX leads to enhanced sensitivity to
protein farnesyl transferase inhibitors but not other
classes of drugs
Our group has characterized and optimized protein farneysl-
transferase inhibitor molecules based on the tetrahydroquinoline
(THQ) scaffold [33]. LN-59 is a THQ compound (Structure 4 g in
reference 32) that has potent activity against mammalian PFT (IC50
of 3.2 nM) and Plasmodium falciparum PFT (IC50 of 1.1 nM) [33].
Additionally LN-59 has activity against TB-PFT (IC50 of 35 nM)
and against T. brucei 427 bloodstream-form parasites in whole cell
screens (EC50 of 63 nM) suggesting TB-PFT is the target of growth
inhibition. In proliferation assays, T. brucei depleted of Kinesin
CaaX
by RNAi had enhanced sensitivity to LN-59 (Fig. 6A). In five
independent experiments, effective concentrations of LN-59 to
reduce proliferation by 50% (EC50s) were 4.2 fold less in the
Kinesin
CaaX -depleted cells compared with non-induced controls
(SD of 1.0, Student T Test p,0.001). T. brucei depleted of
Kinesin
CaaX by RNAi were not hypersensitive to DFMO (Fig. 6B)
or pentamidine (Fig. 6C), compounds that do not act through
inhibition of TB-PFT. DFMO and pentamidine were tested three
times each, and thesameEC50s were observed whether tet-induced
to reduce Kinesin
CaaX or not. Additionally we tested another RNAi
line, which gave similar growth reduction to that of Kinesin
CaaX
upon tetracycline induction, a glycogen synthase kinase (GSK)
RNAi line [34]. T. brucei depleted of GSK by RNAi were not
hypersensitive to LN-59 (Fig. 6D), DFMO (Fig. 6E), or pentamidine
(Fig. 6F). These assays demonstrate that cells with reduced
Kinesin
CaaX are more sensitive to a PFT inhibitor but not two
drugs from other classes. These data demonstratethat depletion of a
CaaX-containing molecular target sensitizes T. brucei to protein
farnesyltransferase inhibition of cell growth.
Discussion
Our analysis reveals an important role for Kinesin
CaaX in the
cell growth of T. brucei. In this study we have demonstrated
Kinesin
CaaX has motor activity along microtubules and is essential
for growth in the bloodstream form. Kinesin
CaaX depleted cells
(RNAi-induced cells) demonstrate an increase of cells with less
than a G1 complement of DNA, which are presumably dying.
Kinesin
CaaX-depleted cells have more rounded cell bodies
compared to control uninduced T. brucei cells. This change in
morphology could be a direct effect of reduced Kinesin
CaaX or an
indirect effect of cell death. Supporting that rounded cells were
dying, the rounded cells that predominated during RNAi
appeared to have weaker DAPI staining, implying their nuclei
were undergoing degradation. Exogenous expression cell lines
show HA-Kinesin
CaaX is highly enriched near the anterior
kinetoplast and near the nucleus in 2K1N containing cells and
between post-mitotic nuclei in 2K2N containing cells prior to
cytokinesis. In our exogenous expression lines, cells with 2K1N
and 2K2N content had more easily detectable Kinesin
CaaX
relative to 1K1N cells perhaps suggesting a role in separation of
nuclei and kinetoplasts. HA-Kinesin
CaaX was found to overlay b-
tubulin in this area between 2 nuclei in 2K2N cells and this
localization may also support a role for Kinesin
CaaX in the
separation of nuclei. It is possible that post-transcriptional
regulation of Kinesin
CaaX levels, such as protein instability, could
be responsible for the reduced detection of Kinesin
CaaX in 1K1N
cells. Kinesin Family 5 and Family 7 members responsible for
chromosome separation in higher organisms are lacking in T.
brucei [24]. Due to localization and increased abundance of HA-
Kinesin
CaaX in cells near kinetoplast and nuclear DNA, we
hypothesize that Kinesin
CaaX may facilitate nuclear and kineto-
plast segregation.
Our radiolabeling studies show that HA-Kinesin
CaaX but not HA-
Kinesin
CVIM deletion is a target for prenylation in T. brucei cells. To
uncover the role of farnesylation in Kinesin
CaaX,w el o c a l i z e d
ectopically-expressed HA-Kinesin
CVIM deletion.H A - K i n e s i n
CVIM deletion
expression results in a more diffuse localization pattern compared with
HA-Kinesin
CaaX
. This supports the hypothesis that farnesylation helps
Kinesin
CaaX appropriately localize in the cell. Prolonged ectopic
expression of HA-Kinesin
CVIM deletion leads to cells with rounded cell
bodies and reduced DNA content, a phenotype we also observed in the
RNAi experiments. We speculate this apparent increase in cell death
occurs due to an accumulation of Kinesin
CVIM deletion molecules
without prenylation, outcompeting the endogenous Kinesin
CaaX
for functional interactions. We speculate the delayed 96 hour
Kinesin
CVIM deletion effect, compared to the early phenotype that is
evident at 48 hours in the RNAi experiments, may be due to
heterodimers of native Kinesin
CaaX and HA-Kinesin
CVIM deletion being
functional at 48 hours after tet-induction and homodimers of HA-
Kinesin
CVIM deletion that accumulate 96 hours after tet-induction may
not localize or function properly. We hypothesize Kinesin
CaaXinteracts
with cellular cargo via the farnesyl group at the C-terminus, and the
motor domain at the N-terminus allows the Kinesin
CaaX to move along
microtubules of the cell. Future experiments are needed define the
cargo of Kinesin
CaaX.
We also show Kinesin
CaaX RNAi cells have an increased
sensitivity to a protein farnesyl transferase inhibitor (PFTi) but not
other classes of drugs when compared to cells with wildtype levels
of Kinesin
CaaX. Collectively these data suggest that farnesylation of
Kinesin
CaaX is integral to the function of Kinesin
CaaX. This is the
first study of a molecular target downstream of T. brucei protein
farnesyl transferase (TB-PFT). While there are many proteins with
CaaX motifs in T. brucei that may be modified by TB-PFT (Fig.
S1), our data, of increased sensitivity to PFTi when Kinesin
CaaX is
reduced, suggest that inhibition of farnesylation of Kinesin
CaaX
contributes substantially to the growth inhibition of PFTi-treated
T. brucei.
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including T. brucei, was unable to group Kinesin
CaaX with other
known kinesin family members [35]. In our work, we show the
essential motor motifs are intact in Kinesin
CaaX (Fig. 1) and
demonstrate ATP-dependent motor activity characteristic of
kinesins (Fig. S4B). Based on the localization pattern during
various stages of the cell cycle, we speculate Kinesin
CaaX may be
facilitating factors key to kinetoplast and nuclear DNA segrega-
tion. Centromeric protein E (CENP-E) is a kinesin in higher
eukaryotic organisms that contains a CaaX box, is farnesylated
and has been shown to be an N-terminal processive motor protein
[36–38], all properties similar to Kinesin
CaaX. CENP-E is a
Kinesin-7 family member and is involved in chromosome
movement during mitosis and links centromeres to spindle
microtubules. Similar to the observed levels in expression of
HA-Kinesin
CaaX, CENP-E has the maximum level during late G2
and minimal levels in G1 [37]. CENP-E localization to
kinetochores occurs from early premetaphase through anaphase.
CENP-E is important during all phases of mitotic chromosome
movement and affects kinetochore-microtubule capture. CENP-E
Figure 5. Deletion of CVIM amino acids from Kinesin
CaaX results in a more diffuse localization of Kinesin
CVIM deletion. (A) Left Western
blot of whole cell lysates of bloodstream form (BSF) T. brucei tagged HA- Kinesin
CVIM deletion cell line either induced (+) or non-induced (2) for
48 hours. Right Quantitative PCR (qPCR) showed induced cells had 13.9 fold increase in mRNA for Kinesin
CVIM deletion than non-induced controls
(error bars are SD). (B) Flow cytometry reveals little change at up to 48 hours post tetracycline induction of exogenous HA-Kinesin
CaaX expression.
Fragmented cells are seen at 72–96, similar to the phenotype observed in RNAi cells at 48 hours. (C) Cells tetracycline-induced for 24 hours, fixed and
stained with DAPI to stain nuclear and kinetoplast DNA (blue), FITC-anti-mouse IgG to stain mouse anti-b tubulin KMX antibody(green) and anti-HA
rat mAb primary and polyclonal anti-IgG Cy5.5 (red) secondary.
doi:10.1371/journal.pone.0026508.g005
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Additionally the use of protein farnesyl transferase inhibitors has
been shown to block the association of CENP-E with microtubules
[38]. Currently no CENP-E homolog or any Kinesin-7 family
member has been uncovered in the Tritryp genomes by
bioinformatic studies [24]. Several other kinesins have recently
been characterized in T. brucei including the C-terminal Kinesin-
13 proteins [39,40] TbKif13-1 is associated with the nucleus and
nuclei in a non cell-cycle dependent manner [40]. Depletion of
TbKif13-1 in T. brucei results in an increase in G2/M cells by
48 hours and causes altered minichromosome segregation [39].
We speculate Kinesin
CaaX may play a role in nuclear and
kinetoplast segregation. Kinetochores, the multimeric protein
structures that attach at the centromere spindle microtubules to
chromosomes during cell division, have not been observed in T.
brucei. Peripheral microtubules structures that are suggestive of
pole-kinetochore microtubules have been observed in T. brucei.
These peripheral microtubules terminate in electron dense
structures and these structures may be serving as conventional
kinetochores. However, there is a discrepancy between the
number of large chromosomes, 22 in the diploid set of T. brucei
and the 10 electron dense structures seen in T. brucei cells [41].
Minichromosomes are hypothesized to segregate from the
microtubule spindle through tracking along microtubules that
extend to the poles rather than via a conventional kinetochore
attachment [41]. In mammalian cells, the inner kinetochore
attaches to the DNA at the centromeric region while the outer
kinetochore proteins interact with the spindle microtubules.
Bioinformatic analysis of the Tritryp (T. brucei, L. major, T. cruzi)
genomes does not reveal homologs for most of the proteins of the
outer kinetochore including CENP-E, CENP-F, HEC1/Ndc80,
Nuf2 or for inner kinetochore components including CENP-C,
CENP-G, Cep3p, Mis12, Nde10p and Ctf13p [24]. One outer
kinetochore protein, TOG/MOR1 and two inner kinetochore
proteins, MCAK and Skp1p have been annotated in the TriTryps
[24] yet their roles in T. brucei have not been characterized. As
Tritryps do not encode homologs to the majority of conventional
kinetochore components other proteins must facilitate successful
segregation of their DNA. Our work demonstrates the same
pattern of accumulation of Kinesin
CaaX throughout the cell cycle
as seen with other reported studies on CENP-E. Kinesin
CaaX and
the associated farnesyl group may function in a similar manner as
CENP-E creating additional interactions with microtubules at the
C-terminus of Kinesin
CaaX via the farnesyl group, and thus move
microtubules associated with chromosomes, nuclei or kinetoplasts
along other microtubules. Alternatively, the farnesyl group may
provide a hydrophobic attachment to a membrane target, such as
nuclear membranes, allowing nuclear movement during cytoki-
nesis. Thus, CENP-E shares many similarities with Kinesin
CaaX
and we hypothesize that this kinesin performs functions in
trypanosomatids that CENP-E performs in higher eukaryotes.
In preparation of this manuscript, Kinesin
CaaX was identified
among a list of proteins in a palmitoylation screen [42]. We
speculate based on the cysteine conserved three amino acids
before the CaaX motif that this protein is both palmitoylated and
farnesylated. We note that the cysteine residue three residues
upstream of the CaaX motif is also conserved in all pathogenic
kinetoplastids (Fig. S2). While we did not remove the cysteine
where palmitoylation may occur, palmitoylation in this context
usually requires farnesylation which does not occur if the
CaaX motif is removed. Thus we hypothesize that our HA-
Kinesin
CVIMdeleted construct lacks both post-translational modifi-
cations and both modifications contribute to proper localization.
In conclusion our work characterizes a kinetoplastid-specific
kinesin that has a site for farnesylation, undergoes farneyslation in
T. brucei and requires farnesylation for proper function. We
hypothesize this farnesylation could facilitate interactions with
microtubules, as is the case with CENP-E and H-ras and N-ras in
Figure 6. RNAi of Kinesin
CaaX show enhanced sensitivity to protein farnesyl transferase inhibitors but not other drugs. (A) LN-59 (B)
DFMO and (C) Pentamidine mean % growth (normalized to no drug) in induced and noninduced Kinesin
CaaX RNAi cells. (D) LN-59 (E) DFMO and (F)
Pentamidine mean % growth in induced and noninduced GSK RNAi line. Values normalized to no drug with error bars representing SD.
doi:10.1371/journal.pone.0026508.g006
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membrane. Our work suggests inhibition of farnesylation of
Kinesin
CaaX contributes to the molecular mechanism of growth
arrest in PFTi-treated T. brucei. This is the first study to
demonstrate motor activity of a T. brucei kinesin and the first
study to characterize farnesylation of a kinesin in T. brucei. Further
understanding of Kinesin
CaaX and of interacting partners of
Kinesin
CaaX in T. brucei and other pathogenic kinetoplasts may be
helpful to finding new therapeutic interventions for these parasitic
pathogens.
Materials and Methods
Cell maintenance
The single marker bloodstream form (BSF) strain T. brucei brucei
427 cell line that expresses T7 RNA polymerase and Tet-repressor
[43] was maintained in HMI-9 medium containing 10%
tetracycline-free fetal bovine serum (Atlanta Biologicals). Cultures
were maintained at 37uC with 5% CO2 as previously described
[39]. Cells were diluted into fresh medium once cell density
achieved 2610
6 cells/mL.
Generation of Kinesin
CaaX RNAi cell lines
Using the primer prediction algorithm, RNAit [44], primers
were selected to minimize off-target effects. The 600 nucleotide
sequence was amplified from the full length Kinesin
CaaX ORF of
the expression plasmid and confirmed to contain Kinesin
CaaX by
dye deoxy sequencing. The 600 base pair PCR product was
analyzed by gel electrophoresis and compared with the predicted
product size. The RNAi vector p2T7
TAblue [45] (gift from David
Horn) was cut to remove the stuffer region and gel purified. The
PCR product was then ligated into p2T7
TAblue and transformed
into E. coli DH5alpha. Plasmids were screened by restriction
enzyme digestion and verified by dye deoxy sequencing prior to
trypanosome transformation. Midlog T. brucei (2.5610
7) were
resuspended in cytomix (120 mM KCl, 0.15 mM CaCl2,1 0m M
K2HPO4/KH2PO4 pH 7.6, 25 mM HEPES, 2 mM Na2EDTA,
5 mM MgCl2) containing 12 mgo fNotI linearized p2T7
TAblue
DNA. The mixture was electroporated in a 4 mm gap cuvette with
1.6 kV and 24V resistance. Cells were resuspended in HMI-9
media. After 6 hours of recovery, selective drug (2.5 mg/mL
hygromycin and 2.5 mg/mL G418) was applied and serial
dilutions were made into 24-well plates. Transfected cells grew
out from limit diluted cells in 6 to 8 days after electroporation.
Construction of Kinesin
CaaX expression strains
T h ec o m p l e t eo p e nr e a d i n gf r a m eo ft h eT. brucei Kinesin
CaaX was
amplified using T. brucei brucei g e n o m i cD N A ,s t r a i n4 2 7 ,u s i n g
primers with an added HindIII and BamHI sequences for subcloning
and a N terminal double HA tag using primers 59CCAAAAAG-
TAAAATTCACTATCCATATGACGTCCCAGACTCTGCCT-
ATCCATATGACGTCCCAGACTCTGCCAAGCTTATGTC-
GGGTATATATGCG39 and antisense 59CCGGCTACATTAT-
TATTACACAGTAATGGCAACCC39.T h eH At a gw a se n g i -
neered with the AatI restriction site (GACGTC) to test for insertion.
The PCR product was analyzed by gel electrophoresis and gel
purified. The expression vector pHD
538 [46] (gift from Christine
Clayton) was cut to remove the stuffer region and gel purified. The
PCR product was then ligated into the vector and transformed intoE.
coli DH5alpha. Plasmids were isolated using QIAGEN kits, screened
by restriction enzyme digestion, verified by dye deoxy sequencing,
analyzed using Vector NTI Suite 9.0 (Invitrogen) and linearized with
Not I prior to trypanosome transformation. Trypanosome transfor-
mation and drug selection were performed as described above.
Removal of CVIM from Kinesin
CaaX
Using the pHD
538 Kinesin
CaaX as template we performed site
directed mutagenesis using the primers 59TAAACAGGGTTGC-
CATTACTAGGGATCCAATTTTCCCC93
59 GGGGAAAATTGGATCCCTAGTAATGGCAACCCT-
GTTTA93 and the Pfu Ultra polymerase to remove the entire
CaaX motif, in order to explore the function of Kinesin
CaaX when
it was not farnesylated as previously described [47]. As the
protease that acts after farnesylation removes the VIM residues,
we felt that removing the entire CVIM terminus would lead to a
better physiologic demonstration of what functionally happens to
Kinesin
CaaX without prenylation. Amplification conditions were
5 minutes at 95uC, followed by 12 cycles of 1 minute at 95uC,
1 minute at 55uC and 18 minutes at 68uC. The PCR reaction was
then Dpn I treated overnight to digest the parental plasmid DNA
and transformed into E. coli XL10-Gold cells (Invitrogen).
Plasmids were screened by restriction enzyme digestion, verified
by dye deoxy sequencing to have the desired deletion, analyzed
using Vector NTI Suite 9.0 (Invitrogen) and linearized with Not I
prior to trypanosome transformation as described above for
Kinesin
CaaX.
RT-PCR
Total RNA was extracted from mid-logarithmic phase cultures
of T. brucei using the Qiagen RNeasy Mini kit. mRNA was isolated
using the Qiagen Oligotex system from 10 mg of total RNA.
Reverse transcription using 25 ng of mRNA per reaction using
random hexamers with TaqMan Reverse Transcription Reagents
(Applied Biosystems) yielded cDNA. Samples without reverse
transcriptase were included to confirm the absence of contami-
nating genomic DNA. cDNA reactions were diluted two-fold and
amplified in 25 mL reactions containing 2.5 mL of each cDNA,
5 mL each of 1.5 mM sense and antisense primers, and 12.5 mL
SYBR Green PCR Master Mix (Applied Biosystems) in 96-well
plates using the Opticon 2 Real-Time PCR Detection System
(BioRad Life Sciences). Amplification conditions were 2 minutes
at 50uC and 10 minutes at 95uC, followed by 45 cycles of
15 seconds at 95uC, 1 minute at 55uC and 1 minute 30 seconds at
60uC, 1 second at 80uC. Using the primers corresponding to the
254–353 basepair region, sense 59-GCTCCAACCGAACGT-
AACTC-39 and antisense 59-CACTTCCCGCTAAGTCAACC-
39. Additionally tubulin primers used as a control were sense 59-
TTCCGCACCCTGAAACTGA-39 and antisense 59-TGACG-
CCGGACACAACAG-39. Relative changes were determined
after normalization to b-tubulin mRNA and expressed as relative
mRNA abundance from the respective control cells.
Production of Polyclonal antibody against Kinesin
CaaX
protein
The T. brucei Kinesin
CaaX amino acids 409–525 corresponding
to the least similar region to other T. brucei proteins, as analyzed by
BLAST [48], was amplified using the full length gene from the
expression plasmids as template using the LIC primers sense
59CTCACCACCACCACCACCAT39 and antisense 59ATCC-
TATCTTACTCACTTA39 coding for an N-terminally 6Xhisti-
dine-tagged Kinesin
CaaX fragment. Nine amino acid segments
were checked against the T. brucei genome using BLAST to ensure
the specificity to Kinesin
CaaX. The PCR product was then put into
the LIC expression vector Bg1861 and transformed into E. coli
NovaBlue cells (Novagen). Plasmids were screened by restriction
enzyme digestion, verified by dye deoxy sequencing and analyzed
using Vector NTI Suite 9.0 (Invitrogen). The recombinant plasmid
was then transformed into E. coli BL21cells (Promega) and grown
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harvested by centrifugation at 2,500 g for 10 minutes at 4uC.
Bacterial cells were lysed in lysis buffer (50 mM Tris, 100 mM
NaCl, 1 mM MgCl2, and Protease Inhibitor Cocktail (Sigma-
P8430), pH 7.0) and purified using Nickel-NTA resin (QIAGEN).
The purified recombinant protein was dialyzed against PBS. The
purified recombinant protein was sequenced using trypsin
digestion and mass spectrometry to verify peptide purity. The
purified recombinant protein was used to raise rabbit polyclonal
antibodies (R&R Rabbitry). Rabbit serum was preblocked with E.
coli lysate to reduce nonspecific binding prior to Western blot.
Western Blot
Western blots were performed using 12 mg of total protein
induced or noninduced T. brucei cultures run on 12% SDS PAGE
gels and transferred to PVDF membrane.
Membranes were blocked with 5% nonfat dry milk in Tris
buffered saline with 0.1% Tween 20 (TBS-T) on an orbital shaker
overnight at 4uC. Rabbit serum was preabsorbed with E. coli
lysates overnight. Preabsorbed rabbit serum was diluted 1:500 in
blocking buffer and incubated with the membranes on a shaker for
1 hour at RT. Membranes were washed three times with TBS-T
for 10 minutes. Next anti-rabbit secondary antibody conjugated to
HRP (Pierce) was added and incubated on a shaker for 1 hour at
RT. The membrane was rinsed with TBS-T three times with TBS-
T for 10 minutes and developed using ECL Plus (Amersham).
Anti-HA Westerns were performed with 3F10 (Roche) 1:1000 as a
primary antibody and secondary anti-Rat antibody, ab6517
(abcam), 1:15:000.
Immunofluorescense microscopy
Cells were washed with PBS, applied to poly-lysine-coated
Teflon slides and allowed to adhere. Cells were fixed with 4%
paraformaldehyde (PFA) for 5 minutes, washed three times with
PBS and permeabilized with 0.05% Triton X at room temper-
ature. Samples were then blocked overnight at 4uC with 5% BSA
supplemented with 5% goat serum. The following antibodies were
used: The KMX-1 b-tubulin monoclonal antibody [32] (gift from
Keith Gull); the High Affinity anti-HA rat mAb 3F10 (Roche);
goat polyclonal to rat IgG-H&L Cy5.5 (abcam), FITC-conjugated
anti-rabbit IgG (Sigma-Aldrich), anti-mouse IgG 568 (abcam).
Fixed cells were incubated with primary antibodies at room
temperature for 60 minutes, washed three times and incubated
with FITC-conjugated and Cy5.5 conjugated antibodies for
another 60 minutes. After washing three more times, the cells
were stained with 1.0 mg/uL of 4, 6-diamino-2-phenlyindole
(DAPI) and the slides were mounted with Fluoromount G (Sigma-
Aldrich). Cells were examined using a Nikon TE2000 inverted
microscope equipped with a Photometrics CoolSNAP HQ2
camera for fluorescence and phase contrast images. Images were
analyzed using SoftwoRX software and processed for publication
using Adobe Photoshop (Adobe Systems Inc., San Jose, CA) and
ImageJ. Secondary antibody only controls were performed and
gave only background, low-level fluorescence which was used to
set the software for signal detection.
Flow cytometry
Bloodstream form cells were inoculated at 1610
5/mL and
allowed to grow. The cultures were harvested at various time
points, fixed with 4% paraformaldehyde for five minutes, washed
once with PBS and permeabilized with 0.05% Triton X. Lastly
DAPI was added and cells were analyzed with an Influx analytical
flow cytometer (BD Biosciences). Histograms were created using
the FCS Express Version 3 software.
Drug Assays
T. brucei Kinesin
CaaX RNAi line cells were inoculated into 96-
well plates at 2.5610
4/well. To induce dsRNA, 1 mg/mL
tetracycline was added and cells were allowed to grow with
various concentrations of the LN-59 protein farnesyl transferase
inhibitor drug for 48 hours followed by Alamar Blue analysis to
follow cell growth as previously described [43]. Pentamidine and
difluoromethyl ornithine or DFMO (Sigma-Aldrich) were used as
control drugs and compared to cells in media alone. Experiments
were done in triplicate. Best fit curves and EC50 values were fitted
using Prism 3.0 (Graphpad) and Kaleidagraph 4.0 (Synergy
Software). Drug concentrations are expressed in mM.
Prenylation Determination by Radio-labeling
Double HA-tagged Kinesin
CaaX expressing, double HA-tagged
Kinesin
CVIM deletion and control T. brucei cell lines were plated into
6-well plates at 1610
6/well and treated with 1 mg/mL tetracy-
cline, 1.25 mM simvastatin and 6.7 mM (100 mCi) [
3H]-mevalo-
nolactone. Cells were incubated for 48 hours and then processed
for immunoprecipitations. [
3H]-counts were detected using the
MicroBeta Scintillation detector (MicroBeta TriLux, Perkin
Elmer).
Immunoprecipitation
T. brucei cells were incubated in lysis buffer (25 mM Tris-Cl,
pH 7.6, 100 mM NaCl, 1% Nonidet P-40, 1 mM dithiothreitol
and protease inhibitor cocktail) for 30 minutes on ice and cleared
by centrifugation. The cleared lysate was pre-incubated with
protein G Sepharose beads at 4uC for 1 hour. Beads were
removed by centrifugation and the bead-cleared supernatant was
incubated with anti-HA polyclonal antibody and protein G
Sepharose beads at 4uC for two hours. The immune-precipitates
collected were then analyzed in the MicroBeta Scintillation
detector (MicroBeta TriLux, Perkin Elmer).
Supplemental Materials and Methods
Expression and purification of active Kinesin
CaaX in E.
coli. The T. brucei Kinesin
CaaX motor domain was amplified
using the full length gene from the expression plasmids as template
and the ligation independent cloning (LIC) primers 59CTCA-
CCACCACCACCACCATATGTCAGAGGTACTCGATGC-
GC 39 and antisense 59ATCCTATCTTACTCACTTACTC-
ACTTGCAAGAGTACCACTAAG 39 coding for a N-terminally
6Xhistidine-tagged Kinesin
CaaX motor domain protein. The PCR
product was placed into the LIC expression vector Bg1861 [49]
and transformed into E. coli NovaBlue cells (Novagen). Plasmids
were screened by restriction enzyme digestion, checked by dye
deoxy sequencing, and the sequence verified using Vector NTI
Suite 9.0 (Invitrogen). The recombinant plasmid was then
transformed into E. coli BL21cells (Promega) and grown and
induced using IPTG for protein production. Bacteria were
harvested by centrifugation at 2,500 g for 10 minutes at 4uC.
Bacterial cells were lysed in lysis buffer (100 mM NaCl, 1 mM
MgCl2, 1 mM ATP, lysozyme and Protease Inhibitor Cocktail
(Sigma-P8430), pH 7.0) and soluble lysates prepared by
centrifugation at 14,0006 g for 10 minutes. Soluble lysates were
used in the motility assay as described below.
Gliding Motility Assays. Fluorescent microtubules (MT)
were prepared using an 80:1 ratio of unlabeled bovine-to Alexa
568-labeled bovine tubulin, BRB80 buffer (80 mM Pipes/KOH,
pH 6.9, 1 mM EGTA, 1 mM MgCl2), 4 mM MgCl2,1 m M
GTP, and 5% DMSO at 37uC. After 30 minutes the MT
polymers, 5–20 mm in length were stabilized by diluting 200-fold
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Microscope slide flow cells were made using a microscope slide
fitted with two pieces of double sided tape with 1 cm gap and a
coverslip. Motility buffer (BRB80 supplemented with 0.2 mg/mL
casein, 20 mM D-glucose, 0.02 mg/mL glucose oxidase,
0.008 mg/mL catalase, 0.5% 2-mercaptoethanol and 32 nM of
the final polymerized microtubule reaction) with and without+
1 mM MgATP was added to the microscope slide coated with E.
coli soluble lysates containing the recombinant Kinesin
CaaX motor
protein or the b-galactosidase non-motor control. Time lapse
photography was taken every 4 seconds, with a one second
exposure, using a Nikon TE2000 inverted microscope, 1006
objective, with a Photometrics CoolSNAP HQ2 camera for
fluorescence images. Images were analyzed using SoftwoRX
software and processed for publication using Adobe Photoshop
(Adobe Systems Inc.).
Supporting Information
Figure S1 List of CaaX motif containing proteins in T.
brucei. Gene ID, putative name and CaaX motif are listed.
(PDF)
Figure S2 Kinesin
CaaX is conserved in other pathogenic
kinetoplastids. Shown are multiple sequence alignments using
MUSCLE version 3.7 [23]. LmxM18.1600 from Leishmania
mexicana mexicana, LbrM18_V2.1630 from Leishmania braziliensis,
LinJ18_V3.1590 from Leishmania infantum, LmjF18.1600 from
Leishmania major, Tc00.1047053507625.180 from Trypanosoma cruzi,
TvY486_1012140 from Trypanosoma vivax, TcIL3000.10.10660
from Trypanosoma congolense, Tbg972.10.14990 from Trypanosoma
brucei gambiense, and Tb927.10.12440, herein referred to as
Kinesin
CaaX, from Trypanosoma brucei brucei.
(PDF)
Figure S3 Dendrogram of Kinesin
CaaX and orthologs
from other pathogenic kinetoplastids. The evolutionary
relationship of Kinesin
CaaX was analyzed using Biology Work
Bench, Version 3.2, DRAWGRAM and PHYLIP (Phylogeny
Inference Package) version 3.5c [26]. This analysisdemonstrates the
T. brucei gambiense homolog to be most closely related to T. brucei
brucei Kinesin
CaaX followed by the other Trypanosoma species and then
the Leishmania species. For gene ID and species key, see Legend of
Figure S2. Horizontal distances represent relative genetic distance.
(PDF)
Figure S4 Kinesin
CaaX has motor activity in the pres-
ence of ATP in vitro. (A) Recombinant His-tagged truncated N-
terminal 340 AA-construct of Kinesin
CaaX restricted to the
predicted motor domain and the coil region predicted to facilitate
dimerization. (B) Coomassie stained PAGE showing E.coli soluble
lysate used for the motor assays in (C) withthe increased band at the
expected molecular weight (44 kDa) for Kinesin
CaaX motor-domain
upon IPTG jnduction (+). (C)A nin vitro gliding motility assay using
truncated Kinesin
CaaX and fluorescent microtubules. Lysates
containing recombinant truncated Kinesin
CaaX was allowed to
adhere to glass microscope slides. Next rhodamine-labeled
microtubules were added with or without ATP to the slide and
microtubule motility was monitored by time-lapse fluorescence
microscopy. Selected frames from time lapse microscopy are
represented. The positions of rhodamine-labeled microtubules over
time are marked with arrows. (D) Control cell lysates containing
recombinant b-galactosidase non-motor protein control showed no
microtubule movement in the presence of ATP. The positions of
two stationary microtubules are marked with arrows.
(TIF)
Figure S5 Growth rate of T. brucei exogenously ex-
pressing Kinesin
CaaX is not affected after induction but
Kinesin
CVIMdeletion induced cells begin to slow their
growth rate at 96 hrs. Shown are growth curves of blood-
stream T. brucei parasites grown either with (+) or without (2)
tetracycline induction. Control parasites are ‘‘Single Marker’’
parasites without an exogenous expression plasmid. Kinesin
CaaX
and Kinesin
CVIMdeletion are parasites transfected with the exoge-
nous expression vector expressing these proteins under control of
tetracycline induction. Parasite numbers are shown on the Y axis
and time after tetracycline induction in hours is shown on the X
axis. The experiment shown represents a single clone from each
transfection but the same results were also observed with a second
clone from each transfection (data not shown).
(TIF)
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